216
Participants
Start Date
April 30, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
March 31, 2027
EscharEx (EX-03)
a sterile lyophilized powder containing a concentrate of proteolytic enzymes enriched in bromelain (anacaulase-bcdb). The powder and sterile water are mixed to form a gel prior to application on the wound area.
Placebo (Gel vehicle)
A sterile powder containing excipients only (no proteolytic enzymes). The powder and sterile water are mixed to form a gel prior to application on the wound area
ACTIVE_NOT_RECRUITING
Northwell Health Comprehensive Wound Healing Center, Lake Success
RECRUITING
JPS Health Network/Acclaim Multispecialty Clinic, Fort Worth
RECRUITING
University of Texas Health Science Center at San Antonio, San Antonio
NOT_YET_RECRUITING
Limb Preservation Platform, Inc, Fresno
RECRUITING
Center for Clinical Research INC, San Francisco
Lead Sponsor
MediWound Ltd
INDUSTRY